The development of vaccine viruses against pandemic A(H1N1) influenza. - Wikidata - wikimedia - TriplyDB

The development of vaccine viruses against pandemic A(H1N1) influenza.

The development of vaccine viruses against pandemic A(H1N1) influenza.

http://www.wikidata.org/entity/Q30398053

about

Structural Stability of Influenza A(H1N1)pdm09 Virus Hemagglutinins Influenza H1N1pdm-specific maternal antibodies offer limited protection against wild-type virus replication and influence influenza vaccination in ferrets Identification of Influenza A/PR/8/34 Donor Viruses Imparting High Hemagglutinin Yields to Candidate Vaccine Viruses in Eggs Identification of critical residues in the hemagglutinin and neuraminidase of influenza virus H1N1pdm for vaccine virus replication in embryonated chicken eggs Virus-like particle vaccine containing hemagglutinin confers protection against 2009 H1N1 pandemic influenza Development of influenza A(H7N9) candidate vaccine viruses with improved hemagglutinin antigen yield in eggs.Phase 2 assessment of the safety and immunogenicity of two inactivated pandemic monovalent H1N1 vaccines in adults as a component of the U.S. pandemic preparedness plan in 2009.Surface modifications of influenza proteins upon virus inactivation by β-propiolactone A monoclonal antibody-based immunoassay for measuring the potency of 2009 pandemic influenza H1N1 vaccines.Different arms of the adaptive immune system induced by a combination vaccine work in concert to provide enhanced clearance of influenza.Amino acid substitutions in hemagglutinin of the 2009 pandemic influenza A(H1N1) viruses that might affect the viral antigenicity Molecular Characterisation of the Haemagglutinin Glycan-Binding Specificity of Egg-Adapted Vaccine Strains of the Pandemic 2009 H1N1 Swine Influenza A Virus.Construction and Immunogenicity Evaluation of Recombinant Influenza A Viruses Containing Chimeric Hemagglutinin Genes Derived from Genetically Divergent Influenza A H1N1 Subtype Viruses.Development of high-yield influenza A virus vaccine viruses Deep Sequencing for Evaluation of Genetic Stability of Influenza A/California/07/2009 (H1N1) Vaccine Viruses Comparative Efficacy of Monoclonal Antibodies That Bind to Different Epitopes of the 2009 Pandemic H1N1 Influenza Virus Neuraminidase.Receptor specificity of subtype H1 influenza A viruses isolated from swine and humans in the United States.A peptide-based approach to evaluate the adaptability of influenza A virus to humans based on its hemagglutinin proteolytic cleavage site.Improved antigen yield in pandemic H1N1 (2009) candidate vaccine viruses with chimeric hemagglutinin molecules.The ferret as a model organism to study influenza A virus infection.Increased immunogenicity of avian influenza DNA vaccine delivered to the skin using a microneedle patch.Pandemic influenza vaccine: characterization of A/California/07/2009 (H1N1) recombinant hemagglutinin protein and insights into H1N1 antigen stability The controversy over H5N1 transmissibility research: an opportunity to define a practical response to a global threat Synthetic generation of influenza vaccine viruses for rapid response to pandemics.Gene constellation of influenza A virus reassortants with high growth phenotype prepared as seed candidates for vaccine production.Impact of host cell line adaptation on quasispecies composition and glycosylation of influenza A virus hemagglutinin.M2e-displaying virus-like particles with associated RNA promote T helper 1 type adaptive immunity against influenza A.Molecular signature of high yield (growth) influenza a virus reassortants prepared as candidate vaccine seeds.Error-prone pcr-based mutagenesis strategy for rapidly generating high-yield influenza vaccine candidates.Development of one-step real-time PCR assay for titrating trivalent live attenuated influenza vaccines.The Ability of a Non-Egg Adapted (Cell-Like) A(H1N1)pdm09 Virus to Egg-Adapt at HA Loci Other than 222 and 223 and Its Effect on the Yield of Viral Protein.Single PA mutation as a high yield determinant of avian influenza vaccines.Influenza vaccines: from whole virus preparations to recombinant protein technology.Topological N-glycosylation and site-specific N-glycan sulfation of influenza proteins in the highly expressed H1N1 candidate vaccines CAP, a new human suspension cell line for influenza virus production.Pathogenicity testing of influenza candidate vaccine viruses in the ferret model.Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.Rationally Designed Influenza Virus Vaccines That Are Antigenically Stable during Growth in Eggs.Generation of a Genetically Stable High-Fidelity Influenza Vaccine Strain [Narcolepsy with cataplexy: an autoimmune disease?].

P2860

Q27681706-678BB184-429C-45B5-A647-38F37B5CB6E3 Q28395364-81C83091-D28C-471C-A8DD-DF1C83F536E9 Q28396333-FECF3A74-1C1A-44F5-B93B-764B8D9AE338 Q28396825-A12877B1-081E-41ED-8C1E-FA4A177B7A11 Q28741801-155BCB24-C596-4662-B695-0657521DD70A Q30203790-143C0ADC-F8C4-429B-9129-4283315BDC03 Q30224646-9A4B03A5-5351-4821-BFB7-078E38C59DC5 Q30354494-F03D7D2D-8EC4-4F02-A28D-1727BBA99C86 Q30365391-2D2C4A37-81A2-4C1F-81F3-C8F3752710F2 Q30369956-A3143723-7EB0-4F48-A63D-6FFA0EBC44B0 Q30370125-CF80EA32-A143-4CA2-B034-959C6B9E2F2F Q30375465-3F08D704-6F9E-4886-BBD7-54EE25026697 Q30375514-9D35B41A-184B-4AEB-B705-89B2AFD70F07 Q30378710-80B366B2-024C-4E61-A1BA-11F01082C5E2 Q30379542-2B8C27FE-9F1D-4F4F-8880-09BE51E2D436 Q30380287-A434BA95-2A09-4A93-878B-166F5B5E866B Q30399862-6A6E311E-CCA3-4F9A-92F0-9959939A6C8F Q30400507-F086A56A-C672-40A8-B6AC-8C7F306BD8BC Q30401820-BF301543-CA1D-4658-A6B6-F8C0C2737BBC Q30405589-4F6BB2E1-952F-4B06-A336-A8F904766797 Q30415387-A22139C6-1D4C-4B64-9EA2-851F68E8A940 Q30422979-00175D7A-B9A0-456E-9BEA-1FEB0607F96F Q30426929-B5DBA978-1562-428C-8094-F87029020F8D Q30430578-A9DD61A5-DDB5-45CB-95C1-E1A26A4CB4BB Q33939416-6B002B59-DD57-43FA-8FB8-9B07D171194B Q34098121-12A82B57-DC9F-4F25-B5EF-1D434B80DE83 Q34634610-D839C2C2-C608-4C70-ACD1-AC243A67B88D Q34776101-EC869F0A-7DE1-43C0-82B6-15BB1EE7946D Q35706440-B6147984-4BC9-44C2-9DB7-BB5DEE592100 Q35886506-4DF67AE7-9A48-4790-94CE-33676741C02F Q36197334-E3CB06F6-9BAB-4288-B488-7334CD8B69D3 Q37584477-D08E7AC0-AB09-4096-97A9-E9B51BBCB2F1 Q38160083-0740843E-2E1D-47C7-B2EC-83136AA888C4 Q38599044-FB372E74-B31B-4E65-837C-800138DEC98A Q39310257-E1E4664B-B9C9-49B0-8645-626B07AD0B41 Q40067951-0D633B88-FF24-4485-B3A3-C5344A3733A2 Q40097582-8C39BA6D-B423-416C-85B8-4AA59FEC9547 Q40170317-88248D9D-D278-43D2-9323-FDB201038A1E Q40385326-8E5117BB-4BC3-412E-B815-3F95F64DA948 Q41583882-B8881BA7-CF95-487B-B7A3-79511ACE871E

P2860

The development of vaccine viruses against pandemic A(H1N1) influenza.

http://www.wikidata.org/entity/Q30398053

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

The development of vaccine viruses against pandemic A(H1N1) influenza.

@ast

The development of vaccine viruses against pandemic A(H1N1) influenza.

@en

type

label

The development of vaccine viruses against pandemic A(H1N1) influenza.

@ast

The development of vaccine viruses against pandemic A(H1N1) influenza.

@en

prefLabel

The development of vaccine viruses against pandemic A(H1N1) influenza.

@ast

The development of vaccine viruses against pandemic A(H1N1) influenza.

@en

P1433

Q30398053-4125604F-4F0F-45F1-ABC4-D7FF5F667718

P1476

Q30398053-691706EC-2187-4D17-ACA2-015136B78284

P2093

Q30398053-010A5FF6-3D41-4A5B-ADD6-3B33EC08FB52

Q30398053-027E5B72-6C86-48FC-A8D9-4D65A4F75AE1

Q30398053-0C550905-7B2F-4EA7-AF3C-8950A26561B2

Q30398053-0E4CB0E2-5FC2-4B07-8F8E-BC68AA4EC746

Q30398053-0FAFFD79-E771-417F-A3B0-D6AC51203384

Q30398053-128FB35D-D1D2-496D-AB31-D69ADA17B8DE

Q30398053-2D49973A-2115-4E98-A6F7-0AF414CEAF15

Q30398053-2EAB322A-1830-4A4B-ABC3-4ED50B7AD8F6

Q30398053-43AABFF5-9290-4E8E-B00B-E2F4B5B0D722

Q30398053-4C229D04-46CD-4560-8EE3-DA5A1596D9A1

P304

Q30398053-1A30171F-1F0E-48AF-8762-A07264D6E581

P31

Q30398053-58155388-F6B4-4322-9B61-6F1C76C44404

P356

Q30398053-8E28A0BB-94FE-4363-837F-FEA6E0FAC12B

P407

Q30398053-D84E09A5-52E5-4DD7-AE1C-D66F9B76389B

P433

Q30398053-B2DD28EF-C1F7-4E74-BA51-79E11797564D

P478

Q30398053-1639430B-1370-4BC3-9471-3D0E8002ED55

P50

Q30398053-08B805CC-CA94-4817-9E3A-2883358234F0

Q30398053-626C129B-AD94-4F94-80F2-C4AC6187A33E

Q30398053-6E1455F8-96CC-43B6-A0E1-4A4D6B260DC5

Q30398053-6E2899A3-FA05-4D08-9403-F3327B652FDB

Q30398053-90920D4A-2250-4935-BF0C-78856E1215B8

Q30398053-9BAE700F-4AC7-4820-A16A-4AEE95CD146C

Q30398053-B565C47E-CBB5-490C-AA0A-2510244AB5D9

Q30398053-BE375FB9-EE64-4713-B300-C891F291019E

Q30398053-E7AD1369-850F-4A56-94AA-62719E72A117

P577

Q30398053-11486A83-5AAA-4420-84F6-B9200FC75B34

P5875

Q30398053-52B76988-4CD5-481F-8C43-70DB2506D940

P698

Q30398053-02169E3F-EF4D-4BA2-AC06-BC9F162037CB

P921

Q30398053-AC3E41DC-2F05-47E8-BDE0-B5794E7BD5D8

P356

J.VACCINE.2010.12.044

P1433

P1476

The development of vaccine viruses against pandemic A(H1N1) influenza.

@en

P2093

Aleksandr S Lipatov

http://www.w3.org/2001/XMLSchema#string

Alexander Klimov

http://www.w3.org/2001/XMLSchema#string

Anne Curtis

http://www.w3.org/2001/XMLSchema#string

Barbara A Pokorny

http://www.w3.org/2001/XMLSchema#string

Carolyn Nicolson

http://www.w3.org/2001/XMLSchema#string

Catherine Agius

http://www.w3.org/2001/XMLSchema#string

Chantal Wallis

http://www.w3.org/2001/XMLSchema#string

Charles T Davis

http://www.w3.org/2001/XMLSchema#string

Chi Ong

http://www.w3.org/2001/XMLSchema#string

Diane Major

http://www.w3.org/2001/XMLSchema#string

P304

1836-1843

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.VACCINE.2010.12.044

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

Jacqueline M. Katz

Othmar G Engelhardt

Terrence M Tumpey

Taronna R Maines

Jessica A Belser

Kortney M Gustin

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49722537

http://www.w3.org/2001/XMLSchema#string

P698

21199698

http://www.w3.org/2001/XMLSchema#string

P921